Browse > Article
http://dx.doi.org/10.15188/kjopp.2015.02.29.1.72

Herbal Medicine Therapeutic Attempt for Diarrhea Induced by Carcinoid Symptoms of Rectosigmoid Neuroendocrine Tumor with Liver Metastasis Patient : a Case Report  

Jeon, Hyung Joon (East-West Cancer Center, Dunsan Korean Hospital of Daejeon University)
Kim, Jong Min (East-West Cancer Center, Dunsan Korean Hospital of Daejeon University)
Cho, Chong Kwan (East-West Cancer Center, Dunsan Korean Hospital of Daejeon University)
Lee, Yeon Weol (East-West Cancer Center, Dunsan Korean Hospital of Daejeon University)
Yoo, Hwa Seung (East-West Cancer Center, Dunsan Korean Hospital of Daejeon University)
Publication Information
Journal of Physiology & Pathology in Korean Medicine / v.29, no.1, 2015 , pp. 72-78 More about this Journal
Abstract
This study aims to report a case of rectosigmoid neuroendocrine tumor patient with liver metastasis whose outstanding carcinoid symptom was mucosal diarrhea for more than 10 times a day. Three different herbal decoctions were administered orally for the treatment of diarrhea which was among carcinoid symptoms from diffuse metastatic liver lesion. The herbal decoctions given were modified Lijung-tang, modified Sambaek-tang and modified Jeokseokjiuyeoryang-tang. The administration period was 5, 14 and 9 days respectively. Frequency of patient's mucosal diarrhea had increased consistently during hospitalization. It had almost doubled compared to pre-hospitalization up to 27 times/24 hrs. But during the period of modified Sambaek-tang administration, frequency of diarrhea was maintained between 9 to 15 times/24hrs. There was no difference of liver tumors between Nov 16th 2013 and Dec 9th 2013 in computed tomography images. Three conventional established herbal prescriptions administered in this case didn't show any favorable effect on improving mucosal diarrhea induced by carcinoid symptoms of a rectosigmoid neuroendocrine tumor with liver metastasis. Even if modified Sambaek-tang showed partial effect on frequency of diarrhea, we concluded that it was not sufficient to be a therapeutic method of the diarrhea as carcinoid symptom. Furthermore, it is necessary to conduct additional studies about the diarrhea of neuroendocrine tumor with liver metastasis.
Keywords
neuroendocrine tumors; neoplasm metastasis; malignant carcinoid syndrome; diarrhea; herbal medicine;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Jiang, J., Wu, F., Lu, J., Lu, Z., Xu, Q. Anti-inflammatory activity of the aqueous extract from Rhizoma smilacis glabrae. Pharmacol Res 36(4):309-314, 1997.   DOI   ScienceOn
2 Hwang, M.W., Kim, J.N., Song, H.J., Lim, B., Kwon, Y.K., Kim, B.J. Effects of Lizhong Tang on cultured mouse small intestine interstitial cells of Cajal. World J Gastroenterol.,19: 2249-2255, 2013.   DOI   ScienceOn
3 Kim, K.R., Ryu, K.W. Effect of Sambaek-tang water extract on the mucous cell in intestine of the rat. K.H.Univ.O,Med.J., 5: 247-258, 1982.
4 Yu, Z., Zhang, G., Dai, Y., Kou, J., Dou, C., Lu, R. Pharmacological study on the compatibility of cortex Cinnamomi with Halloysitum Rubrum. Zhongguo Zhong Yao Za Zhi., 22: 309-312, 1997.
5 Lee, K., Ryu, B., Kim, J., Yoon, S. Anticathartic Effect of MYRISTICAE SEMEN, GRANATI PERICARPIUM and ALPINIAE KATSUMADAI SEMEN. Korean J. Orient. Int. Med., 27: 459-470, 2006.
6 Palumbo, J.S., Kombrinck, K.W., Drew, A.F., Grimes, T.S., Kiser, J.H., Degen, J.L., Bugge, T.H. Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells. Blood., 96: 3302-3309, 2000.
7 Veenendaal, L.M., Borel Rinkes, I.H., Lips, C.J., van Hillegersberg, R. Liver metastases of neuroendocrine tumours; early reduction of tumour load to improve life expectancy. World J Surg Oncol.,4: 35, 2006.   DOI   ScienceOn
8 Aytac, E., Ozdemir, Y., Ozuner, G. Long term outcomes of neuroendocrine carcinomas (high-grade neuroendocrine tumors) of the colon, rectum, and anal canal. J Visc Surg., 151: 3-7, 2014.   DOI   ScienceOn
9 Fiorentini, G., Aliberti, C., Mulazzani, L., Coschiera, P., Catalano, V., Rossi, D., Giordani, P., Ricci, S. Chemoembolization in colorectal liver metastases: the rebirth. Anticancer Res., 34: 575-584, 2014.
10 Harring, T.R., Nguyen, N.T., Goss, J.A., O'Mahony, C.A. Treatment of liver metastases in patients with neuroendocrine tumors: a comprehensive review. Int J Hepatol 154541, 2014. doi: 10.4061/2011/154541.   DOI
11 Ardill, J.E., Erikkson, B. The importance of the measurement of circulating markers in patients with neuroendocrine tumours of the pancreas and gut. Endocr Relat Cancer.,10: 459-462, 2003.   DOI   ScienceOn
12 Lee, J.L., Yu, C.S., Kim, M., Hong, S.M., Lim, S.B., Kim, J.C. Prognostic impact of diagnosing colorectal neuroendocrine carcinoma using the World Health Organization 2010 classification. Surgery.,155: 650-658, 2014.   DOI   ScienceOn
13 Zeng, Y.J., Lai, W., Liu, L., Wu, H., Luo, X.X., Wang, J., Chu, Z.H. Prognostic Significance of Neuroendocrine Differentiation in Colorectal Adenocarcinoma After Radical Operation: a Meta-analysis. J Gastrointest Surg 2014. doi: 10.1007/s11605-014-2480-x.   DOI   ScienceOn
14 Kvols, L.K., Moertel, C.G., O'Connell, M.J., Schutt, A.J., Rubin, J., Hahn, R.G. Treatment of the malignant carcinoid syndrome. N Engl J Med 315(11):663-666, 1986.   DOI   ScienceOn
15 Oberg, K., Castellano, D. Current knowledge on diagnosis and staging of neuroendocrine tumors. Cancer Metastasis Rev., 1: 3-7, 2011.   DOI
16 Modlin, I.M., Lye, K.D., Kidd, M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer.,97: 934-959, 2013.   DOI   ScienceOn
17 Cho, C.S., Labow, D.M., Tang, L., Klimstra, D.S., Loeffler, A.G., Leverson, G.E., Fong, Y., Jarnagin, W.R., D'Angelica, M.I., Weber, S.M., Blumgart, L.H., Dematteo, R.P. Histologic grade is correlated with outcome after resection of hepatic neuroendocrine neoplasms. Cancer., 113: 126-134, 2008.   DOI   ScienceOn
18 Starzynska, T., Deptala, A., Krolicki, L., Kunikowska, J., Londzin-Olesik, M., Nasierowska-Guttmejer, A., Ruchala, M., Strzelczyk, J., Szawlowski, A., Zgliczynski, W., Kos-Kudla, B. Colorectal neuroendocrine neoplasms - management guidelines (recommended by the Polish Network of Neuroendocrine Tumours). Endokrynol Pol., 64: 494-504, 2013.   DOI   ScienceOn
19 Cheung, T.T., Chok, K.S., Chan, A.C., Tsang, S., Dai, J.W., Lang, B.H., Yau, T., Chan, S.C., Poon, R.T., Fan, S.T., Lo, C.M. Long term survival analysis of hepatectomy for neuroendocrine tumour liver metastases. ScientificWorldJournal 524045, 2014. doi:10.1155/2014/524045   DOI
20 Ihse, I., Lindell, G., Tibblin, S. Neuroendocrine tumors metastatic to the liver. In: Holzheimer, R.G. MJ, editor. Surgical Treatment: Evidence-Based and Problem-Oriented: Zuckschwerdt; 2001.